HI
BIO icon

Handelsinvest Investeringsforvaltning’s Bio-Rad Laboratories Class A BIO Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$268K Sell
775
-403
-34% -$133K 0.13% 194
2023
Q4 		$380K Buy
+1,178
New +$369K 0.16% 200

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's BIO Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Bio-Rad Laboratories Class A (BIO) stake by 34% in Q1 2024, selling an estimated $133K and leaving 775 shares worth $268K. The position accounts for 0.13% of the portfolio, ranked #194.

Handelsinvest Investeringsforvaltning first reported a position in BIO in Q4 2023 and has held it in 2 quarters since. The position peaked at $380K in Q4 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 775 shares of Bio-Rad Laboratories Class A worth $268K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 403 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $133K.
  • Bio-Rad Laboratories Class A made up 0.13% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #194 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Bio-Rad Laboratories Class A position peaked at $380K in Q4 2023.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.